Serotonin solves decades-old mystery in Parkinson's disease

June 30, 2010, AAAS
PET image of a healthy brain. Credit: Image courtesy of Marios Politis

Sudden, uncontrolled movements called dyskinesias—a common side effect of treatment for Parkinson’s disease— are a result of excess serotonin cells in transplanted tissue that trick the brain into releasing dopamine, suggests a new study of two Parkinson's disease patients that received fetal tissue transplants over a decade ago, researchers report in the June 30 issue of Science Translational Medicine.

The study sheds light on the long term consequences of brain tissue transplants and may help improve future trials that consist of transplanting cells from other sources, such as bioengineered cells or . Pioneering surgeries performed with aborted fetal tissue in the 1980’s in patients with Parkinson’s proved that the diseased brain could be repaired, at least in some cases. The treatment aimed to replace decayed cells in the brain’s of Parkinson’s patients. Some transplanted patients showed remarkable improvement but eventually the majority developed dyskinesias.

The controversy surrounding the transplantation of fetal into adults put an end to human trials in the United States in the late 1980’s when the U.S. government temporarily banned fetal tissue research, though research continued in other parts of the world. The U.S. ban was lifted in the early 1990’s, but the cause of dyskinesias in these patients remained a mystery, and no effective treatment has been found.

Now, Marios Politis and colleagues in the United Kingdom and Sweden have discovered that the is the culprit. Using imaging scans and radioactive tracers, the researchers were able to visualize the function of different chemicals in the two patient’s brains. Taking a closer look, they found that previously decayed dopamine neurons—a hallmark of Parkinson’s disease—were still restored and fully functional over a decade after transplantation. But Politis and colleagues also saw unexpectedly high amounts of serotonin neurons in the transplanted tissue.

The finding is puzzling because the usual dyskinesias in Parkinson’s are thought to be a result of dopamine action, not serotonin. The researchers discovered that the deceptive ability of serotonin neurons to switch to a different neurotransmitter—to adopt and pump out dopamine—causes the dyskinesias. Administering a drug to block this action almost immediately eliminated the dyskinesias in both patients. The authors also suggest that removing in any future cell-based therapies might prevent this crippling side effect. Recently, a new trial launched under the name TRANSEURO plans to use fetal cell therapy to treat , with the first surgeries planned in 2012.

More information: "Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants," by M. Politis et al. Science Translational Medicine.

Related Stories

Recommended for you

Scientists produce human intestinal lining that re-creates living tissue inside organ-chip

February 16, 2018
Investigators have demonstrated how cells of a human intestinal lining created outside an individual's body mirror living tissue when placed inside microengineered Intestine-Chips, opening the door to personalized testing ...

Data wave hits health care

February 16, 2018
Technology used by Facebook, Google and Amazon to turn spoken language into text, recognize faces and target advertising could help doctors fight one of the deadliest infections in American hospitals.

Researcher explains how statistics, neuroscience improve anesthesiology

February 16, 2018
It's intuitive that anesthesia operates in the brain, but the standard protocol among anesthesiologists when monitoring and dosing patients during surgery is to rely on indirect signs of arousal like movement, and changes ...

Team reports progress in pursuit of sickle cell cure

February 16, 2018
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.

Appetite-controlling molecule could prevent 'rebound' weight gain after dieting

February 15, 2018
Scientists have revealed how mice control their appetite when under stress such as cold temperatures and starvation, according to a new study by Monash University and St Vincent's Institute in Melbourne. The results shed ...

First study of radiation exposure in human gut Organ Chip device offers hope for better radioprotective drugs

February 14, 2018
Chernobyl. Three Mile Island. Fukushima. Accidents at nuclear power plants can potentially cause massive destruction and expose workers and civilians to dangerous levels of radiation that lead to cancerous genetic mutations ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jul 07, 2010
How can there be an excess of serotonin in Parkinson's? Serotonin is responsible for happiness (among other things) - and a deficiency of the neurotransmitter leads to depression, which is strongly connected to PD itself. In fact, many patients with Parkinson's - more than 50% - are also diagnosed with depression. Wouldn't it make sense if there was less - rather than an excess of - serotonin?
It would be great if you could clear this up for me. Thanks.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.